Also known as: Antiepileptics, Seizure medications
Anticonvulsants treat epilepsy, bipolar disorder, trigeminal neuralgia, and neuropathic pain. The most consequential pharmacogenetic signal in this class is not about metabolism but about hypersensitivity: HLA-B*15:02 carriers have a dramatically elevated risk of Stevens-Johnson syndrome on carbamazepine and oxcarbazepine, and the FDA recommends pre-treatment screening in at-risk populations. Phenytoin and fosphenytoin also have CYP2C9-related dose considerations.
Each link goes to the drug's full pharmacogenetics page with CPIC and FDA phenotype recommendations.
Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.
This page covers the pharmacogenetics of anticonvulsants in general. A Gene2Rx report tells you how your personal genotype interacts with every drug on this page.
Get your report Look up a medicationInformational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.